Owner Ganymed Pharmaceuticals AG

Inventors Koslowski, Michael; Sahin, Ugur; Tureci, Ozlem

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012216265

Parent 2008258158

Filing date 16 August 2012

Wipo publication date 6 September 2012

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 39/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 Antineoplastic agents

C07K 14/435 Peptides having more than 20 amino acids - from animals

C07K 14/47 Peptides having more than 20 amino acids

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/09 Undifferentiated human, animal or plant cells, e.g. cell lines - Tumour cells

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 38/00 Medicinal preparations containing peptides